'Armored' CAR T Cells Show Early Promise in Relapsed B-Cell ALL

(MedPage Today) — At the recent American Society of Hematology annual meeting, phase I data highlighted a next-generation, CD19-targeted, interleukin-18-secreting “armored” CAR T-cell therapy that is designed to enhance persistence and antileukemic…

Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearlsall/119164

Author :

Publish date : 2025-12-23 17:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

‘Armored’ CAR T Cells Show Early Promise in Relapsed B-Cell ALL

FDA Approves First Oral Medication for Iron Deficiency in Kids

Long-Term Tofersen Use May Slow ALS Progression, 3-Year Data Suggest

Related Posts

Preventing Shoulder Injury Related to Vaccine Administration

U.S. Signs New Health Deals With 9 African Countries That Mirror Trump’s Priorities

Brain Care Score Predicts Stroke Risk Across Racial Groups

Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer

Single-Pill Approach Proves Beneficial in Hypertension

Alzheimer’s Paper Retracted; Lipoic Acid and MS; Botched Autism Drug Rollout

Preventing Shoulder Injury Related to Vaccine Administration

U.S. Signs New Health Deals With 9 African Countries That Mirror Trump’s Priorities

Brain Care Score Predicts Stroke Risk Across Racial Groups

Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer

Single-Pill Approach Proves Beneficial in Hypertension

Alzheimer’s Paper Retracted; Lipoic Acid and MS; Botched Autism Drug Rollout

Assessing Non-Glandular Manifestations of Sjogren’s Disease

Prediabetes Reversal Benefits; Many Seniors Quit GLP-1s in a Year; Testosterone Fads

Categories

Archives